Alpha Cognition (ACOG) Amortization - Intangibles (2024 - 2025)
Alpha Cognition's (ACOG) quarterly Amortization - Intangibles came in at $5386.0 in Q4 2025, down 72.74% year-on-year from $19760.0 in Q4 2024, and little changed quarter-over-quarter from $5387.0 in Q3 2025.
Alpha Cognition (ACOG) Amortization - Intangibles (2024 - 2025) Analysis & Trends
Alpha Cognition's Amortization - Intangibles history runs 2 years deep, the most recent figure standing at $5386.0 for Q4 2025.
- On a quarterly basis, Amortization - Intangibles fell 72.74% year-over-year to $5386.0 in Q4 2025; TTM through Dec 2025 was $21546.0, a 73.03% decrease from a year earlier, with the FY2025 full-year figure at $21546.0, down 73.03% from the prior year.
- Amortization - Intangibles steadied at $5386.0 in Q4 2025 per ACOG's latest filing, from $5387.0 in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $20594.0 in Q1 2024 and bottomed at $5386.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,386.00 |
| Sep 30, 2025 | 5,387.00 |
| Jun 30, 2025 | 5,386.00 |
| Mar 31, 2025 | 5,387.00 |
| Dec 31, 2024 | 19,760.00 |
| Sep 30, 2024 | 19,761.00 |
| Jun 30, 2024 | 19,760.00 |
| Mar 31, 2024 | 20,594.00 |